LUVOX Side Effects

7021684-8 | Intentional Overdose
on Sep 15, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose. Luvox dosage: 75 Milligram(s); Oral. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6979621-8 | Anger, Bipolar Disorder, Disturbance In Attention, Hostility, Irritability, Mental Status Changes, Morbid Thoughts
Patient was taking Luvox (View Usage). Patient had the following side effects: anger, bipolar disorder (What is bipolar disorder?), disturbance in attention, hostility, irritability, mental status changes, morbid thoughts on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 204.0 lb, was diagnosed with dysthymic disorder, anxiety (What is anxiety?) and. Luvox dosage: 200 Total -half Of 100mg Cap Daily Po. During the same period patient was treated with FIORICET (View Fioricet Review and Fioricet Label ), BYSTOLIC (View Bystolic Review and Bystolic Label ), VIT D (View Vit D Review and Vit D Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ZYTEC (View Zytec Review and Zytec Label ), CLARITIN (View Claritin Review and Claritin Label ), ATIVAN (View Ativan Review and Ativan Label ).

6971760-0 | Erythema Multiforme
Adverse event was reported on Aug 16, 2010 by a Male patient taking Luvox (View Usage) (Dosage: 75 Milligram(s) Oral) was diagnosed with social phobia and. Location: JAPAN , child 8 years of age, After Luvox was administered, patient had the following side effects: erythema multiforme. Patient was hospitalized.

6971129-9 | Hepatic Enzyme Increased, Liver Disorder
on Aug 04, 2010 Female patient from JAPAN , 71 years of age, was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, liver disorder. Luvox dosage: 50 Milligram (s) Oral. During the same period patient was treated with DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), CALBLOCK (AZELNIDIPINE) (View Calblock (azelnidipine) Review and Calblock (azelnidipine) Label ), GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), RIKKUNSHI TO (HESPERIDIN AND L ARGININE) (View Rikkunshi-to (hesperidin And L-arginine) Review and Rikkunshi-to (hesperidin And L-arginine) Label ), KENTON (TOCOPHEROL NICOTINATE) (View Kenton (tocopherol Nicotinate) Review and Kenton (tocopherol Nicotinate) Label ), LAC B (BIFIDOBACTERIUM) (View Lac-b (bifidobacterium) Review and Lac-b (bifidobacterium) Label ). Patient was hospitalized.


6971105-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Serotonin Syndrome
on Aug 23, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, serotonin syndrome. Luvox dosage: 200 Milligram (s) Oral. Patient was hospitalized.

6971103-2 | Breast Calcifications, Breast Cancer, Paranoia
Patient was taking Luvox (View Usage). After Luvox was administered, patient had the following side effects: breast calcifications, breast cancer (What is breast cancer?), paranoia on Aug 19, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, . Luvox dosage: 50 Milligram (s) Oral. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ), DEPAKENE R (SODIUM VALPROATE) (View Depakene-r (sodium Valproate) Review and Depakene-r (sodium Valproate) Label ), JZOLOFT (SERTRALINE HYDROCHLORIDE) (View Jzoloft (sertraline Hydrochloride) Review and Jzoloft (sertraline Hydrochloride) Label ), BROTIZOLAM (BROTIZOLAM) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ), ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ).

6938705-0 | Anxiety, Catatonia, Depression, Pain, Pain In Extremity, Stress
Adverse event was reported on Aug 04, 2010 by a Female patient taking Luvox (View Usage) (Dosage: 100 Mg (100 Mg, 1 In 1 D), Oral, 200 Mg (200 Mg, 1 In 1 D, Oral) was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?), depression (What is depression?) and. Location: UNITED STATES , 34 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), catatonia, depression (What is depression?), pain (What is pain?), pain in extremity, stress (What is stress?). During the same period patient was treated with ARIPIPRAZOLE (1 Dosage Forms, Oral) (View Aripiprazole Review and Aripiprazole Label ), THYROID (View Thyroid Review and Thyroid Label ). Patient was hospitalized.

6938701-3 | Asthenia, Dizziness, Ear Injury, Fall, Head Injury, Limb Injury, Multiple Injuries, Muscle Spasms, Muscular Weakness
on Aug 03, 2010 Female patient from UNITED STATES , 62 years of age, weighting 155.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Luvox (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), ear injury, fall (What is fall?), head injury, limb injury, multiple injuries, muscle spasms, muscular weakness. Luvox dosage: 100 Mg (100 Mg, 1 In 1 D), Oral, 200 Mg (200 Mg, 1 In 1 D), Oral.

6920161-X | Convulsion
on Jul 14, 2010 Female patient from AUSTRALIA , 32 years of age, was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: convulsion. Luvox dosage: . During the same period patient was treated with EFFEXOR (75 Milligram(s)) (View Effexor Review and Effexor Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6920152-9 | Liver Disorder
Patient was taking Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Jul 15, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, . Luvox dosage: 50 Milligram(s) Oral. During the same period patient was treated with DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), CALBLOCK (AZELNIDIPINE) (View Calblock (azelnidipine) Review and Calblock (azelnidipine) Label ), GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), RIKKUNSHI TO (HESPERIDIN AND L ARGININE) (View Rikkunshi-to (hesperidin And L-arginine) Review and Rikkunshi-to (hesperidin And L-arginine) Label ), KENTON (TOCOPHEROL NICOTINATE) (View Kenton (tocopherol Nicotinate) Review and Kenton (tocopherol Nicotinate) Label ), LAC B (BIFIDOBACTERIUM) (View Lac-b (bifidobacterium) Review and Lac-b (bifidobacterium) Label ). Patient was hospitalized.

6920149-9 | Serotonin Syndrome
Adverse event was reported on Jul 22, 2010 by a Female patient taking Luvox (View Usage) (Dosage: Oral) was diagnosed with depression (What is depression?) and. Location: JAPAN , 60 years of age, Patient had the following side effects: serotonin syndrome. Patient was hospitalized.

6871083-4 | Activation Syndrome, Blood Alkaline Phosphatase Increased, Haemoglobin Decreased, Impulsive Behaviour, Irritability, Mean Cell Volume Decreased, Red Blood Cell Count Increased, Restlessness, Suicidal Ideation
on Jul 16, 2010 Female patient from JAPAN , child 10 years of age, was diagnosed with anxiety disorder and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: activation syndrome, blood alkaline phosphatase increased, haemoglobin decreased, impulsive behaviour, irritability, mean cell volume decreased, red blood cell count increased, restlessness, suicidal ideation. Luvox dosage: 12.5 Milligram(s), 25 Milligram(s). During the same period patient was treated with RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ).

6871024-X | Gastrooesophagitis, Hepatic Enzyme Increased, Hepatitis C Virus Test Positive, Jaundice, Liver Disorder, Malaise
on Jul 05, 2010 Female patient from JAPAN , 32 years of age, was diagnosed with depression (What is depression?), gastrooesophagitis and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: gastrooesophagitis, hepatic enzyme increased, hepatitis c virus test positive, jaundice (What is jaundice?), liver disorder, malaise. Luvox dosage: 75 Milligram(s), 25 Milligram(s). During the same period patient was treated with FAMOTIDINE (40 Milligram(s)) (View Famotidine Review and Famotidine Label ), PRIMPERAN TAB (3 Dosage Form) (View Primperan Tab Review and Primperan Tab Label ), MUCOSTA (REBAMIPIDE) (3 Dosage Form) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), NAUZELIN (DOMPERIDONE) (3 Dosage Form) (View Nauzelin (domperidone) Review and Nauzelin (domperidone) Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), LEVOTOMIN (LEVOMEPROMAZINE MALEATE) (View Levotomin (levomepromazine Maleate) Review and Levotomin (levomepromazine Maleate) Label ), HALCION (View Halcion Review and Halcion Label ). Patient was hospitalized.

6870748-8 | Gastrointestinal Disorder, Overdose, Suicide Attempt
Patient was taking Luvox (View Usage). Patient had the following side effects: gastrointestinal disorder, overdose, suicide attempt on Jul 02, 2010 from JAPAN Additional patient health information: Female patient , 39 years of age, . Luvox dosage: 55 Dosage Form.

6870728-2 | Listless, Overdose
Adverse event was reported on Jun 30, 2010 by a Female patient taking Luvox (View Usage) (Dosage: Oral) . Location: JAPAN , 32 years of age, After Luvox was administered, patient had the following side effects: listless, overdose. During the same period patient was treated with BAFHAMERITIN M (MEFENAMIC ACID) (Oral) (View Bafhameritin-m (mefenamic Acid) Review and Bafhameritin-m (mefenamic Acid) Label ).

6870722-1 | Apparent Life Threatening Event, Blood Cholesterol Decreased, Blood Glucose Increased, Blood Sodium Increased, Neutrophil Count Increased, No Therapeutic Response, Pancytopenia
on Jun 30, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: apparent life threatening event, blood cholesterol decreased, blood glucose increased, blood sodium increased, neutrophil count increased, no therapeutic response, pancytopenia. Luvox dosage: See Image. During the same period patient was treated with EC DOPARL (LEVODOPA_BENSERAZIDE HYDROCHLORIDE) (View Ec-doparl (levodopa_benserazide Hydrochloride) Review and Ec-doparl (levodopa_benserazide Hydrochloride) Label ), YOKU KAN (YOKU KAN SAN) (View Yoku-kan (yoku-kan-san) Review and Yoku-kan (yoku-kan-san) Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ).

6870718-X | Blood Chloride Increased, Blood Cholesterol Decreased, Blood Glucose Increased, Blood Sodium Increased, Monocyte Percentage Increased, Neutrophil Percentage Increased, Pancytopenia
on Jun 17, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: blood chloride increased, blood cholesterol decreased, blood glucose increased, blood sodium increased, monocyte percentage increased, neutrophil percentage increased, pancytopenia. Luvox dosage: See Image. During the same period patient was treated with EC DOPARL (LEVODOPA_BENSERAZIDE HYDROCHLORIDE) (View Ec-doparl (levodopa_benserazide Hydrochloride) Review and Ec-doparl (levodopa_benserazide Hydrochloride) Label ), YOKU KAN SAN (YOKU KAN SAN) (View Yoku-kan-san (yoku-kan-san) Review and Yoku-kan-san (yoku-kan-san) Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ).

6870692-6 | Coma, Intentional Overdose, Suicide Attempt
Patient was taking Luvox (View Usage). After Luvox was administered, patient had the following side effects: coma, intentional overdose, suicide attempt on Jul 05, 2010 from BRAZIL Additional patient health information: Female patient , 49 years of age, . Luvox dosage: Oral. During the same period patient was treated with CHLORPROMAZINE (Oral) (View Chlorpromazine Review and Chlorpromazine Label ), CLONAZEPAM (Oral) (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (Oral) (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6870668-9 | Fatigue, Haematocrit Decreased, Haemoglobin Decreased, Intestinal Haemorrhage, Melaena, Platelet Count Decreased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jun 28, 2010 by a Female patient taking Luvox (View Usage) (Dosage: See Image) was diagnosed with obsessive-compulsive personality disorder and. Location: JAPAN , 41 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, haematocrit decreased, haemoglobin decreased, intestinal haemorrhage, melaena, platelet count decreased, red blood cell count decreased, white blood cell count decreased.

6836490-4 | Anxiety, Catatonia, Pain, Pain In Extremity, Stress
on Jun 23, 2010 Female patient from UNITED STATES , 34 years of age, weighting 180.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Luvox (View Usage). Patient had the following side effects: anxiety (What is anxiety?), catatonia, pain (What is pain?), pain in extremity, stress (What is stress?). Luvox dosage: 100 Mg (100 Mg, 1 In 1 D), Oral; 200 Mg (200 Mg, 1 In 1 D), Oral. During the same period patient was treated with ARIPIPRAZOLE ((1 Dosage Forms, Once)) (View Aripiprazole Review and Aripiprazole Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ). Patient was hospitalized.

6832680-5 | Pancytopenia
on Jun 04, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: pancytopenia. Luvox dosage: 50 Milligram(s), Oral. During the same period patient was treated with EC DOPRAL (LEVODOPA_BENSERAZIDE HYDROCHLORIDE) (View Ec-dopral (levodopa_benserazide Hydrochloride) Review and Ec-dopral (levodopa_benserazide Hydrochloride) Label ), YOKU KAN SAN (YOKU KAN SAN) (View Yoku-kan-san (yoku-kan-san) Review and Yoku-kan-san (yoku-kan-san) Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), LIVALO (LIVALO) (View Livalo (livalo) Review and Livalo (livalo) Label ), GASLON (IRSOGLADINE MALEATE) (View Gaslon (irsogladine Maleate) Review and Gaslon (irsogladine Maleate) Label ).

6832671-4 | Anaemia, Central Nervous System Lesion, Contusion, Convulsion, Haematochezia, Hypoaesthesia, Hypoaesthesia Facial, Insomnia, Oedema Peripheral
Patient was taking Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, central nervous system lesion, contusion, convulsion, haematochezia, hypoaesthesia, hypoaesthesia facial, insomnia, oedema peripheral on Jun 16, 2010 from CANADA Additional patient health information: Male patient , 42 years of age, . Luvox dosage: 100 Milligram(s), Oral; 50 Milligram(s), Oral. During the same period patient was treated with IMOVANE (ZOPICLONE) (View Imovane (zopiclone) Review and Imovane (zopiclone) Label ).

6832670-2 | Dyskinesia, Parkinsonism
Adverse event was reported on Jun 22, 2010 by a Female patient taking Luvox (View Usage) (Dosage: Oral) . Location: JAPAN , 78 years of age, Patient had the following side effects: dyskinesia, parkinsonism. During the same period patient was treated with DESYREL (View Desyrel Review and Desyrel Label ).

6832665-9 | Gastrointestinal Disorder, Overdose
on Jun 22, 2010 Female patient from JAPAN , 39 years of age, was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: gastrointestinal disorder, overdose. Luvox dosage: 55 Dosage Form, Oral.

6798930-9 | Liver Disorder
on Jun 02, 2010 Female patient from JAPAN , 32 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Luvox dosage: 25 Milligram(s) Oral. During the same period patient was treated with FAMOTIDINE (40 Milligram(s), Oral) (View Famotidine Review and Famotidine Label ), PRIMPERAN TAB (Oral) (View Primperan Tab Review and Primperan Tab Label ), PAXIL (40 Milligram(s), Oral) (View Paxil Review and Paxil Label ), LEVOTOMIN (LEVOMEPROMAZINE MALEATE) (5 Milligram(s), Oral) (View Levotomin (levomepromazine Maleate) Review and Levotomin (levomepromazine Maleate) Label ), HALCION (0.25 Milligram(s), Oral) (View Halcion Review and Halcion Label ), MUCOSTA (REBAMIPIDE) (300 Milligram(s), Oral) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

6797689-9 | Activation Syndrome, Impulsive Behaviour, Irritability, Suicidal Ideation
Patient was taking Luvox (View Usage). Patient had the following side effects: activation syndrome, impulsive behaviour, irritability, suicidal ideation on May 28, 2010 from JAPAN Additional patient health information: Female patient , 20 years of age, . Luvox dosage: 12.5 Milligram(s) Oral; 25 Milligram(s) Oral. During the same period patient was treated with RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ).

6797668-1 | Convulsion, Depressed Level Of Consciousness
Adverse event was reported on Jun 01, 2010 by a Male patient taking Luvox (View Usage) (Dosage: 75 Milligram(s) Oral) . Location: JAPAN , 71 years of age, After Luvox was administered, patient had the following side effects: convulsion, depressed level of consciousness. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), ARICEPT (View Aricept Review and Aricept Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), PAROTIN (SALIVARY GLAND HORMONE) (View Parotin (salivary Gland Hormone) Review and Parotin (salivary Gland Hormone) Label ), HALCION (View Halcion Review and Halcion Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), MUCODYNE (CARBOCISTEINE) (View Mucodyne (carbocisteine) Review and Mucodyne (carbocisteine) Label ). Patient was hospitalized.

6759531-1 | Alanine Aminotransferase Increased, Apparent Life Threatening Event, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Somnolence
on May 18, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with depression (What is depression?), multiple myeloma (What is multiple myeloma?) and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, apparent life threatening event, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, somnolence. Luvox dosage: 25 Milligram(s) Oral. During the same period patient was treated with COTRIM (Oral) (View Cotrim Review and Cotrim Label ), NOVAMINE 15% (10 Milligram(s) Oral) (View Novamine 15% Review and Novamine 15% Label ), FLURBIPROFEN (Other) (View Flurbiprofen Review and Flurbiprofen Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ALOSENN (SENNA LEAF SENNA POD) (View Alosenn (senna Leaf-senna Pod) Review and Alosenn (senna Leaf-senna Pod) Label ), MAGMITT (MAGNESIUM OXIDE) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ). Patient was hospitalized.

6759527-X | Alcohol Use, Anxiety, Delusion, Hallucination, Auditory, Hallucination, Visual, Homicide, Paranoia, Psychotic Disorder
on May 05, 2010 Male patient from AUSTRALIA , 18 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: alcohol use, anxiety (What is anxiety?), delusion, hallucination, auditory, hallucination, visual, homicide, paranoia, psychotic disorder (What is psychotic disorder?). Luvox dosage: 300 Milligram(s) Oral. During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), ALCOHOL (ALCOHOL) (View Alcohol (alcohol) Review and Alcohol (alcohol) Label ).

6759526-8 | Blood Sodium Decreased, Gait Disturbance, Memory Impairment, Normal Pressure Hydrocephalus, Pain In Extremity, Paraesthesia, Rhabdomyolysis
Patient was taking Luvox (View Usage). After Luvox was administered, patient had the following side effects: blood sodium decreased, gait disturbance, memory impairment, normal pressure hydrocephalus, pain in extremity, paraesthesia, rhabdomyolysis on May 05, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, . Luvox dosage: 75 Milligram(s) Oral, Oral. During the same period patient was treated with SULPIRIDE (SULPIRIDE) (150 Milligram(s) Oral) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), PROPIVERINE HYDROCHLORIDE (PROPIVERINE HYDROCHLORIDE) (View Propiverine Hydrochloride (propiverine Hydrochloride) Review and Propiverine Hydrochloride (propiverine Hydrochloride) Label ).

6723366-6 | Anxiety, Delusion, Hallucination, Auditory, Hallucination, Visual, Homicide, Paranoia, Psychotic Disorder
Adverse event was reported on Apr 27, 2010 by a Male patient taking Luvox (View Usage) (Dosage: 300 Milligram(s), Oral) was diagnosed with depression (What is depression?) and. Location: AUSTRALIA , 18 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), delusion, hallucination, auditory, hallucination, visual, homicide, paranoia, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with VALIUM (View Valium Review and Valium Label ).

6723364-2 | Alanine Aminotransferase Increased, Antinuclear Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Calcium Decreased, Blood Lactate Dehydrogenase Increased, Blood Urea Decreased, Gamma-glutamyltransferase Increased, Haematocrit Decreased
on Apr 16, 2010 Female patient from JAPAN , 14 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium decreased, blood lactate dehydrogenase increased, blood urea decreased, gamma-glutamyltransferase increased, haematocrit decreased. Luvox dosage: 50 Milligram(s), Oral. During the same period patient was treated with RISPERDAL (1 Milligram(s), Oral) (View Risperdal Review and Risperdal Label ), MEILAX (ETHYL LOFLAZEPATE) (1 Milligram(s), Oral) (View Meilax (ethyl Loflazepate) Review and Meilax (ethyl Loflazepate) Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ). Patient was hospitalized.

6723363-0 | Suicide Attempt, Unevaluable Event
on Apr 14, 2010 Female patient from JAPAN , 25 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: suicide attempt, unevaluable event. Luvox dosage: 50 Milligram(s), Oral. During the same period patient was treated with PAXIL (40 Milligram(s), Oral) (View Paxil Review and Paxil Label ).

6699491-5 | Coma, Intentional Overdose, Listless, Suicide Attempt
Patient was taking Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: coma, intentional overdose, listless, suicide attempt on Apr 13, 2010 from BRAZIL Additional patient health information: Female patient , 49 years of age, was diagnosed with borderline personality disorder, depression (What is depression?) and. Luvox dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6699479-4 | Hepatic Function Abnormal
Adverse event was reported on Apr 08, 2010 by a Female patient taking Luvox (View Usage) (Dosage: 25 Milligram(s)) was diagnosed with depression (What is depression?), multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 62 years of age, Patient had the following side effects: hepatic function abnormal. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), NOVAMINE 15% (10 Milligram(s)) (View Novamine 15% Review and Novamine 15% Label ), ROPION (FLURBIPROFEN AXETIL) (View Ropion (flurbiprofen Axetil) Review and Ropion (flurbiprofen Axetil) Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ALOSENN (SENNA LEAF SENNA POD) (View Alosenn (senna Leaf-senna Pod) Review and Alosenn (senna Leaf-senna Pod) Label ), MAGMITT (MAGNESIUM OXIDE) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ).

6680821-5 | Aggression, Homicidal Ideation
on Mar 30, 2010 Male patient from JAPAN , 43 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: aggression, homicidal ideation. Luvox dosage: 50 Milligram(s). During the same period patient was treated with DOGMATYL (SULPIRIDE) (View Dogmatyl (sulpiride) Review and Dogmatyl (sulpiride) Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), DEPAKENE (View Depakene Review and Depakene Label ).

6679111-6 | Hypophosphataemia, Suicide Attempt
on Mar 22, 2010 Male patient from UNITED STATES , 30 years of age, was diagnosed with suicide attempt and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: hypophosphataemia, suicide attempt. Luvox dosage: (20 Dosage Forms), Oral. Patient was hospitalized.

6667925-8 | Bradycardia, Electrocardiogram Qt Prolonged, Loss Of Consciousness
Patient was taking Luvox (View Usage). Patient had the following side effects: bradycardia, electrocardiogram qt prolonged, loss of consciousness on Mar 12, 2010 from JAPAN Additional patient health information: Female patient , 90 years of age, . Luvox dosage: Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), CALFINA (ALFACALCIDOL) (View Calfina (alfacalcidol) Review and Calfina (alfacalcidol) Label ), ASPARA CA (CALCIUM L ASPARTATE) (View Aspara-ca (calcium L-aspartate) Review and Aspara-ca (calcium L-aspartate) Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ).

6667920-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Sodium Decreased, Cognitive Disorder, Gait Disturbance, Postural Reflex Impairment, Rhabdomyolysis
Adverse event was reported on Mar 12, 2010 by a Male patient taking Luvox (View Usage) (Dosage: 75 Milligram9s) Oral) . Location: JAPAN , 72 years of age, After Luvox was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood sodium decreased, cognitive disorder, gait disturbance, postural reflex impairment, rhabdomyolysis. During the same period patient was treated with SULPIRIDE (SULPIRIDE) (150 Milligram(s), Oral) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), PROPIVERINE HYDROCHLORIDE (PROPIVERINE HYDROCHLORIDE) (View Propiverine Hydrochloride (propiverine Hydrochloride) Review and Propiverine Hydrochloride (propiverine Hydrochloride) Label ).

6667900-3 | Chondrolysis
on Mar 12, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: chondrolysis. Luvox dosage: 1 Dosage Form Oral; See Image. During the same period patient was treated with ARICEPT (3 Milligram(s) Oral) (View Aricept Review and Aricept Label ), NORVASC (View Norvasc Review and Norvasc Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), DOGMATYL (SULPIRIDE) (View Dogmatyl (sulpiride) Review and Dogmatyl (sulpiride) Label ).

6667889-7 | Coma, Intentional Overdose, Suicide Attempt
on Mar 17, 2010 Female patient from BRAZIL , 49 years of age, was diagnosed with borderline personality disorder, depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: coma, intentional overdose, suicide attempt. Luvox dosage: Oral. During the same period patient was treated with CHLORPROMAZINE (Oral) (View Chlorpromazine Review and Chlorpromazine Label ), CLONAZEPAM (Oral) (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (Oral) (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6667871-X | Completed Suicide
Patient was taking Luvox (View Usage). After Luvox was administered, patient had the following side effects: completed suicide on Mar 22, 2010 from AUSTRALIA Additional patient health information: Male patient , 24 years of age, . Luvox dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), AMPHETAMINE SULFATE (View Amphetamine Sulfate Review and Amphetamine Sulfate Label ), CANNABIS PREPARATION (CANNABIS PREPARATION) (View Cannabis Preparation (cannabis Preparation) Review and Cannabis Preparation (cannabis Preparation) Label ).

6667868-X | Intentional Overdose, Suicide Attempt
Adverse event was reported on Mar 19, 2010 by a Female patient taking Luvox (View Usage) (Dosage: 50 Milligram(s) Oral) was diagnosed with depression (What is depression?) and. Location: JAPAN , 14 years of age, Patient experienced the following unwanted or unexpected effects: intentional overdose, suicide attempt. During the same period patient was treated with RISPERDAL (1 Milligram(s), Oral) (View Risperdal Review and Risperdal Label ), MEILAX (ETHYL LOFLAZEPATE) (1 Milligram(s), Oral) (View Meilax (ethyl Loflazepate) Review and Meilax (ethyl Loflazepate) Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ). Patient was hospitalized.

6655295-0 | Hepatic Function Abnormal
on Mar 08, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with depression (What is depression?) and was treated with Luvox (View Usage). Patient had the following side effects: hepatic function abnormal. Luvox dosage: 25 Milligram(s) Oral. During the same period patient was treated with COTRIM (Oral) (View Cotrim Review and Cotrim Label ), NOVAMIN (PROCHLORPERAZINE MALEATE) (50 Milligram(s), Oral) (View Novamin (prochlorperazine Maleate) Review and Novamin (prochlorperazine Maleate) Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ALOSENN (SENNA LEAF SENNA POD) (View Alosenn (senna Leaf-senna Pod) Review and Alosenn (senna Leaf-senna Pod) Label ), MAGMITT (MAGNESIUM OXIDE) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), RIZE (CLOTIAZEPAM) (View Rize (clotiazepam) Review and Rize (clotiazepam) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPARA POTASSIUM (POTASSIUM L ASPARTATE) (View Aspara Potassium (potassium L-aspartate) Review and Aspara Potassium (potassium L-aspartate) Label ). Patient was hospitalized.

6655292-5 | Intentional Overdose, Serotonin Syndrome, Suicide Attempt
on Mar 04, 2010 Male patient from JAPAN , 30 years of age, was diagnosed with intentional overdose, obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: intentional overdose, serotonin syndrome, suicide attempt. Luvox dosage: 5200 Milligram(s), Soral. During the same period patient was treated with PAROXETINE HCL (680 Milligram(s), Oral) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6655290-1 | Agoraphobia, Anxiety, Dissociative Amnesia, Overdose, Self Injurious Behaviour, Somnolence, Suicide Attempt, Tension
Patient was taking Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: agoraphobia, anxiety (What is anxiety?), dissociative amnesia, overdose, self injurious behaviour, somnolence, suicide attempt, tension on Mar 04, 2010 from JAPAN Additional patient health information: Female patient , 20 years of age, was diagnosed with depression (What is depression?), insomnia and. Luvox dosage: See Image. During the same period patient was treated with RONFLEMAN (BROTIZOLAM) (0.25 Milligram(s), Oral; 4.25 Milligram(s), Oral) (View Ronfleman (brotizolam) Review and Ronfleman (brotizolam) Label ).

6655242-1 | Abdominal Pain, Gastrointestinal Disorder, Phlebosclerosis, Vomiting
Adverse event was reported on Feb 03, 2010 by a Female patient taking Luvox (View Usage) (Dosage: Oral) . Location: JAPAN , 61 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), gastrointestinal disorder, phlebosclerosis, vomiting. During the same period patient was treated with CLOTIAZEPAM (CLOTIAZEPAM) (View Clotiazepam (clotiazepam) Review and Clotiazepam (clotiazepam) Label ), BROMAZEPAM (BROMAZEPAM) (View Bromazepam (bromazepam) Review and Bromazepam (bromazepam) Label ), LACTOMIN (LACTOBACILLUS SPOROGENES) (View Lactomin (lactobacillus Sporogenes) Review and Lactomin (lactobacillus Sporogenes) Label ), ALBUMIN TANNATE (ALBUMIN TANNATE) (View Albumin Tannate (albumin Tannate) Review and Albumin Tannate (albumin Tannate) Label ), MEPENZOLATE BROMIDE (MEPENZOLATE BROMIDE) (View Mepenzolate Bromide (mepenzolate Bromide) Review and Mepenzolate Bromide (mepenzolate Bromide) Label ), ETIZOLAM (ETIZOLAM) (View Etizolam (etizolam) Review and Etizolam (etizolam) Label ), PRANLUKAST HYDRATE (PRANLUKAST HYDRATE) (View Pranlukast Hydrate (pranlukast Hydrate) Review and Pranlukast Hydrate (pranlukast Hydrate) Label ), BUNAZOSIN HYDROCHLORIDE (BUNAZOSIN HYDROCHLORIDE) (View Bunazosin Hydrochloride (bunazosin Hydrochloride) Review and Bunazosin Hydrochloride (bunazosin Hydrochloride) Label ).

6644482-3 | Altered State Of Consciousness, Convulsion, Hyperhidrosis, Intentional Overdose, Listless, Mydriasis, Myoclonus, Neuroleptic Malignant Syndrome, Pyrexia
on Feb 16, 2010 Male patient from JAPAN , 30 years of age, was diagnosed with intentional overdose, obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Luvox (View Usage). After Luvox was administered, patient had the following side effects: altered state of consciousness, convulsion, hyperhidrosis, intentional overdose, listless, mydriasis, myoclonus, neuroleptic malignant syndrome, pyrexia. Luvox dosage: Oral; 5200 Milligram(s), Oral. During the same period patient was treated with PAROXETINE HCL (680 Milligram(s), Oral) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6644460-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Sodium Decreased, Gamma-glutamyltransferase Increased, Red Blood Cell Count Decreased, Rhabdomyolysis
on Feb 24, 2010 Male patient from JAPAN , 72 years of age, was treated with Luvox (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood sodium decreased, gamma-glutamyltransferase increased, red blood cell count decreased, rhabdomyolysis. Luvox dosage: 75 Milligram(s), Oral. During the same period patient was treated with SULPIRIDE (SULPIRIDE) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), PROPIVERINE HYDROCHLORIDE (PROPIVERINE HYDROCHLORIDE) (View Propiverine Hydrochloride (propiverine Hydrochloride) Review and Propiverine Hydrochloride (propiverine Hydrochloride) Label ).

6644444-6 | Intentional Overdose, Long Qt Syndrome, Serotonin Syndrome, Therapeutic Agent Toxicity
Patient was taking Luvox (View Usage). Patient had the following side effects: intentional overdose, long qt syndrome, serotonin syndrome, therapeutic agent toxicity on Mar 03, 2010 from JAPAN Additional patient health information: Female patient , 19 years of age, was diagnosed with depression (What is depression?) and. Luvox dosage: 50 Milligram(s), Oral; 3475 Milligram(s), Oral. During the same period patient was treated with GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ). Patient was hospitalized.